HUE036797T2 - Oleanolsav C17-heteroaril-származékai és azok alkalmazási eljárásai - Google Patents

Oleanolsav C17-heteroaril-származékai és azok alkalmazási eljárásai

Info

Publication number
HUE036797T2
HUE036797T2 HUE13767175A HUE13767175A HUE036797T2 HU E036797 T2 HUE036797 T2 HU E036797T2 HU E13767175 A HUE13767175 A HU E13767175A HU E13767175 A HUE13767175 A HU E13767175A HU E036797 T2 HUE036797 T2 HU E036797T2
Authority
HU
Hungary
Prior art keywords
methods
oleanolic acid
heteroaryl derivatives
heteroaryl
derivatives
Prior art date
Application number
HUE13767175A
Other languages
English (en)
Inventor
Xin Jiang
Christopher Bender
Melean Visnick
Original Assignee
Reata Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reata Pharmaceuticals Inc filed Critical Reata Pharmaceuticals Inc
Publication of HUE036797T2 publication Critical patent/HUE036797T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Lubricants (AREA)
  • Steroid Compounds (AREA)
HUE13767175A 2012-09-10 2013-09-10 Oleanolsav C17-heteroaril-származékai és azok alkalmazási eljárásai HUE036797T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261699199P 2012-09-10 2012-09-10

Publications (1)

Publication Number Publication Date
HUE036797T2 true HUE036797T2 (hu) 2018-07-30

Family

ID=49253401

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13767175A HUE036797T2 (hu) 2012-09-10 2013-09-10 Oleanolsav C17-heteroaril-származékai és azok alkalmazási eljárásai

Country Status (28)

Country Link
US (1) US20140088163A1 (hu)
EP (1) EP2892911B1 (hu)
JP (1) JP6272870B2 (hu)
KR (1) KR102237364B1 (hu)
CN (1) CN104768965B (hu)
AU (1) AU2013312102B2 (hu)
BR (1) BR112015005200B1 (hu)
CA (1) CA2882417C (hu)
CY (1) CY1119762T1 (hu)
DK (1) DK2892911T3 (hu)
EA (1) EA029069B1 (hu)
ES (1) ES2644615T3 (hu)
HK (1) HK1211295A1 (hu)
HR (1) HRP20171565T1 (hu)
HU (1) HUE036797T2 (hu)
IL (1) IL237638B (hu)
IN (1) IN2015DN01547A (hu)
LT (1) LT2892911T (hu)
ME (1) ME02911B (hu)
MX (1) MX366954B (hu)
NZ (1) NZ705213A (hu)
PL (1) PL2892911T3 (hu)
PT (1) PT2892911T (hu)
RS (1) RS56563B1 (hu)
SG (1) SG11201501800UA (hu)
SI (1) SI2892911T1 (hu)
WO (1) WO2014040056A1 (hu)
ZA (1) ZA201501203B (hu)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009089545A1 (en) 2008-01-11 2009-07-16 Reata Pharmaceuticals, Inc. Synthetic triterpenoids and methods of use in the treatment of disease
CA2721838C (en) 2008-04-18 2017-05-23 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
MX2010011435A (es) 2008-04-18 2011-01-25 Reata Pharmaceuticals Inc Compuestos que incluyen un nucleo farmaceutico antiinflamatorio y sus metodos de uso.
US8513436B2 (en) 2010-12-17 2013-08-20 Reata Pharmaceuticals, Inc. Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
WO2013163344A1 (en) 2012-04-27 2013-10-31 Reata Pharmaceuticals, Inc. 2.2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
US9556222B2 (en) 2012-06-15 2017-01-31 Reata Pharmaceuticals, Inc. A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
US9512094B2 (en) 2012-09-10 2016-12-06 Reata Pharmaceuticals, Inc. C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
DK2892912T3 (da) 2012-09-10 2019-06-24 Reata Pharmaceuticals Inc C17-alkandiyl og alkenediylderivater af oleanolsyre og fremgangsmåder til anvendelse deraf
TWI649330B (zh) 2013-04-24 2019-02-01 艾伯維有限公司 甲基巴多索龍之2,2-二氟丙醯胺衍生物、其多晶形及其使用方法
KR20240035818A (ko) 2015-02-12 2024-03-18 리아타 파마슈티컬즈, 아이엔씨. 항산화 염증 조절제로서의 이미다졸릴 트리사이클릭 에논
KR20180061251A (ko) 2015-09-23 2018-06-07 리아타 파마슈티컬즈, 아이엔씨. Il-17의 저해를 위한 c4-변형된 올레아놀산 유도체 및 다른 용도
KR102486434B1 (ko) 2016-11-08 2023-01-09 리아타 파마슈티컬즈 홀딩스, 엘엘씨 바독솔론 메틸 또는 이의 유사체를 사용하는 알포트 증후군의 치료 방법
CN106632574B (zh) * 2016-12-07 2018-05-29 广东天键生物科技有限公司 一种化合物、其制备方法及用途
TWI831738B (zh) 2016-12-16 2024-02-11 美商瑞塔醫藥有限責任公司 用於抑制RORγ及其他用途的嘧啶三環烯酮衍生物
JP6820450B2 (ja) 2017-09-14 2021-01-27 フェニックス・バイオテクノロジー・インコーポレイテッド ウイルス感染を治療するための方法および組成物
KR20200083969A (ko) 2017-09-14 2020-07-09 피닉스 바이오테크놀러지 인코포레이티드. 신경학적 상태를 치료하기 위한 방법 및 개선된 신경보호 조성물
US11993574B2 (en) 2018-06-15 2024-05-28 Reata Pharmaceuticals, Inc Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma
CA3114354A1 (en) * 2018-09-28 2020-04-02 Sichuan Haisco Pharmaceutical Co., Ltd. Terpinoid derivatives and uses thereof
KR20220044942A (ko) * 2019-07-19 2022-04-12 리아타 파마슈티컬즈, 아이엔씨. C17 극성-치환된 헤테로방향족 합성 트리터페노이드 및 그의 사용 방법
SG11202105728YA (en) 2020-03-31 2021-11-29 Phoenix Biotechnology Inc Method and compositions for treating coronavirus infection
EP4009981B1 (en) 2020-03-31 2023-08-16 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection
JP7214696B2 (ja) * 2020-10-01 2023-01-30 一般財団法人 化学物質評価研究機構 新規in vitro皮膚感作性試験法
EP4259155A1 (en) 2020-12-11 2023-10-18 Reata Pharmaceuticals Holdings, LLC Synthetic triterpenoids for use in therapy
EP4277916A1 (en) 2021-01-18 2023-11-22 Reata Pharmaceuticals, Inc. Synthetic ursolic acid derivatives and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326507B1 (en) * 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
CA2485565A1 (en) * 2002-05-13 2004-08-05 Trustees Of Dartmouth College Inhibitors and methods of use thereof
WO2009089545A1 (en) 2008-01-11 2009-07-16 Reata Pharmaceuticals, Inc. Synthetic triterpenoids and methods of use in the treatment of disease
BRPI0911422B8 (pt) 2008-04-18 2021-05-25 Reata Pharmaceuticals Inc compostos moduladores inflamatórios antioxidantes, composição farmacêutica e usos dos mesmos
CA2721838C (en) 2008-04-18 2017-05-23 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
CN102164941B (zh) * 2008-04-18 2015-05-27 里亚塔医药公司 抗氧化剂炎症调节剂:具有饱和c环的齐墩果酸衍生物
WO2009146216A2 (en) 2008-04-18 2009-12-03 Reata Pharmaceuticals. Inc. Antioxidant inflammation modulators: novel derivatives of oleanolic acid
MX348862B (es) * 2011-03-11 2017-07-03 Reata Pharmaceuticals Inc Derivados c4-monometil triterpenoides y sus metodos de uso.
US9556222B2 (en) * 2012-06-15 2017-01-31 Reata Pharmaceuticals, Inc. A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof

Also Published As

Publication number Publication date
HK1211295A1 (en) 2016-05-20
EP2892911A1 (en) 2015-07-15
RS56563B1 (sr) 2018-02-28
MX366954B (es) 2019-07-31
BR112015005200B1 (pt) 2022-07-05
BR112015005200A2 (hu) 2017-08-15
LT2892911T (lt) 2017-11-10
IL237638A0 (en) 2015-04-30
EP2892911B1 (en) 2017-08-30
IL237638B (en) 2020-04-30
IN2015DN01547A (hu) 2015-07-03
KR20150053982A (ko) 2015-05-19
CA2882417C (en) 2021-04-20
AU2013312102B2 (en) 2018-03-08
HRP20171565T1 (hr) 2017-12-15
EA029069B1 (ru) 2018-02-28
KR102237364B1 (ko) 2021-04-06
EA201590539A1 (ru) 2015-08-31
JP2015529227A (ja) 2015-10-05
NZ705213A (en) 2018-07-27
MX2015003078A (es) 2015-07-14
DK2892911T3 (en) 2017-10-23
ES2644615T3 (es) 2017-11-29
ZA201501203B (en) 2021-08-25
PT2892911T (pt) 2017-11-02
SG11201501800UA (en) 2015-04-29
CN104768965B (zh) 2018-05-11
WO2014040056A1 (en) 2014-03-13
CY1119762T1 (el) 2018-06-27
SI2892911T1 (sl) 2017-12-29
JP6272870B2 (ja) 2018-01-31
CN104768965A (zh) 2015-07-08
CA2882417A1 (en) 2014-03-13
US20140088163A1 (en) 2014-03-27
PL2892911T3 (pl) 2018-03-30
ME02911B (me) 2018-10-20
AU2013312102A1 (en) 2015-03-12

Similar Documents

Publication Publication Date Title
HK1211295A1 (en) C17-heteroaryl derivatives of oleanolic acid and methods of use thereof c17-
HK1212355A1 (en) C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof c17-
HRP20181628T1 (hr) Spojevi i postupci za njihovu upotrebu
LT2683731T (lt) C4-monometiltriterpenoido dariniai ir jų panaudojimo būdai
EP2912178A4 (en) SUPER AMPLIFIER AND METHOD FOR USE THEREOF
HK1212977A1 (zh) 苯達莫司汀衍生物及其使用方法
IL236965B (en) Derivatives of 5-aminolevulinic acid and uses thereof
EP2986112A4 (en) PREPARATION AND USE OF FULVINIC ACID DERIVATIVES
ZA201408128B (en) Etract of greyia radlkoferi and use thereof